UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 28, 2013

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-10030

APPLE INC.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

Registrant s telephone number, including area code: (408) 996-1010

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the

Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically

and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the

registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer,

an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the

Exchange Act).

Yes No

891,989,000 shares of common stock issued and outstanding as of January 10,

2014

Table of Contents

Apple Inc.

Form 10-Q

For the Fiscal Quarter Ended December 28, 2013

TABLE OF CONTENTS

Page

Part I

Item 1.

Financial Statements

Item 2.

Management s Discussion and Analysis of Financial Condition and Results of Operations

24

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

40

Item 4.

Controls and Procedures

40

Part II

Item 1.

Legal Proceedings

41

Item 1A.

Risk Factors

42

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

54

Item 3.

Defaults Upon Senior Securities

54

Item 5.

Other Information

54

Item 6.

Exhibits

55

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In millions, except number of shares which are reflected in thousands and per share amounts)

Three Months Ended

December 28,

2013

December 29,

2012

Net sales

57,594

54,512

Cost of sales

35,748

33,452

Gross margin

21,846

21,060

Operating expenses:

Research and development

1,330

1,010

Selling, general and administrative

3,053

2,840

Total operating expenses

4,383

3,850

Operating income

17,463

17,210

Other income/(expense), net

246

462

Income before provision for income taxes

17,709

17,672

Provision for income taxes

4,637

4,594

Net income

13,072

13,078

Earnings per share:

Basic

14.59

13.93

Diluted

14.50

13.81

Shares used in computing earnings per share:

Basic

896,072

938,916

Diluted

901,452

947,217

Cash dividends declared per common share

3.05

2.65

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In millions)

Three Months Ended

December 28,

2013

December 29,

2012

Net income

13,072

13,078

Other comprehensive income/(loss):

Change in foreign currency translation, net of tax

(67

(26

Change in unrecognized gains/losses on derivative instruments:

Change in fair value of derivatives, net of tax

213

146

Adjustment for net (gains)/losses realized and included in net income, net of tax

72

112

Total change in unrecognized gains/losses on derivative instruments, net of tax

285

258

Change in unrealized gains/losses on marketable securities:

Change in fair value of marketable securities, net of tax

(42

(66

Adjustment for net (gains)/losses realized and included in net income, net of tax

(11

(53

Total change in unrealized gains/losses on marketable securities, net of tax

(53

(119

Total other comprehensive income/(loss)

165

113

Total comprehensive income

13,237

13,191

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

APPLE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In millions, except number of shares which are reflected in thousands)

December 28,

2013

September 28,

2013

ASSETS:

Current assets:

Cash and cash equivalents

14,077

14,259

Short-term marketable securities

26,634

26,287

Accounts receivable, less allowances of $94 and $99, respectively

14,200

13,102

Inventories

2,122

1,764

Deferred tax assets

3,742

3,453

Vendor non-trade receivables

10,998

7,539

Other current assets

8,574

6,882

Total current assets

80,347

73,286

Long-term marketable securities

118,131

106,215

Property, plant and equipment, net

15,488

16,597

Goodwill

2,022

1,577

Acquired intangible assets, net

4,105

4,179

Other assets

5,091

5,146

Total assets

225,184

207,000

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

29,588

22,367

Accrued expenses

15,824

13,856

Deferred revenue

8,357

7,435

Total current liabilities

53,769

43,658

Deferred revenue non-current

3,071

2,625

Long-term debt

16,961

16,960

Other non-current liabilities

21,699

20,208

Total liabilities

95,500

83,451

Commitments and contingencies

Shareholders equity:

Common stock, no par value; 1,800,000 shares authorized; 892,447 and 899,213 shares issued and outstanding,

respectively

20,559

19,764

Retained earnings

109,431

104,256

Accumulated other comprehensive income/(loss)

(306

(471

Total shareholders equity

129,684

123,549

Total liabilities and shareholders equity

225,184

207,000

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

Three Months Ended

December 28,

2013

December 29,

2012

Cash and cash equivalents, beginning of the period

14,259

10,746

Operating activities:

Net income

13,072

13,078

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation and amortization

2,144

1,588

Share-based compensation expense

681

545

Deferred income tax expense

1,253

1,179

Changes in operating assets and liabilities:

Accounts receivable, net

(1,098

(668

Inventories

(358

(664

Vendor non-trade receivables

(3,459

(2,174

Other current and non-current assets

(319

413

Accounts payable

8,191

6,145

Deferred revenue

1,368

1,611

Other current and non-current liabilities

1,195

2,373

Cash generated by operating activities

22,670

23,426

Investing activities:

Purchases of marketable securities

(48,397

(37,192

Proceeds from maturities of marketable securities

5,556

3,460

Proceeds from sales of marketable securities

30,302

23,002

Payments made in connection with business acquisitions, net

(525

(284

Payments for acquisition of property, plant and equipment

(1,985

(2,317

Payments for acquisition of intangible assets

(59

(138

Other

(52

Cash used in investing activities

(15,103

(13,521

Financing activities:

Proceeds from issuance of common stock

134

76

Excess tax benefits from equity awards

280

404

Taxes paid related to net share settlement of equity awards

(365

(534

Dividends and dividend equivalents paid

(2,769

(2,493

Repurchase of common stock

(5,029

(1,950

Cash used in financing activities

(7,749

(4,497

Increase/(decrease) in cash and cash equivalents

(182

5,408

Cash and cash equivalents, end of the period

14,077

16,154

Supplemental cash flow disclosure:

Cash paid for income taxes, net

3,387

1,890

Cash paid for interest

161

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,

manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and

applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the

Company sells a variety of third-party iPhone, iPad, Mac, and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers; small and mid-sized businesses; and

education, enterprise and government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions

have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the

amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal

year ended September 28, 2013, included in its Annual Report on Form 10-K (the 2013 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is

included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company s fiscal years 2014 and 2013 each include 52 weeks. Unless otherwise stated, references to particular years,

quarters or months refer to the Company s fiscal years ended in September and the associated quarters or months of those fiscal years.

During the first quarter of 2014, the Company adopted updated accounting standards that (i) required disclosure of additional information about the amounts reclassified out of Accumulated Other

Comprehensive Income ( AOCI ) by component and (ii) required gross and net disclosures about offsetting assets and liabilities. The adoption of these updated standards only impacted the disclosures in the Notes to the Condensed

Consolidated Financial Statements; accordingly, the adoption had no impact on the Company s financial position or results of operations. The Company has provided these additional disclosures in this Form 10-Q in Note 8, Comprehensive

Income and Note 2, Financial Instruments, respectively.

Revenue Recognition

In 2013, the Company s combined best estimates of selling price ( ESPs ) for the unspecified software upgrade rights and

the rights to receive the non-software services included with its qualifying hardware devices ranged from $5 to $25. Beginning in the first quarter of 2014, the Company adjusted the combined ESPs for Mac from $20 to $40 to reflect additions to

unspecified software upgrade rights related to expansion of bundled essential software.

Table of Contents

Earnings Per Share

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share

is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been

outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s employee stock purchase plan and unvested restricted stock units

( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the

Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table

shows the computation of basic and diluted earnings per share for the three months ended December 28, 2013 and December 29, 2012 (in thousands, except net income in millions and per share amounts):

Three Months Ended

December 28,

2013

December 29,

2012

Numerator:

Net income

13,072

13,078

Denominator:

Weighted-average shares outstanding

896,072

938,916

Effect of dilutive securities

5,380

8,301

Weighted-average diluted shares

901,452

947,217

Basic earnings per share

14.59

13.93

Diluted earnings per share

14.50

13.81

Potentially dilutive securities representing 0.4 million and 3.7 million shares of common stock

for the three months ended December 28, 2013 and December 29, 2012, respectively, were excluded from the computation of diluted earnings per common share because their effect would have been antidilutive.

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized

gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 28, 2013 and September 28, 2013 (in millions):

December 28, 2013

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

8,404

8,404

8,404

Level 1 (a):

Money market funds

2,236

2,236

2,236

Mutual funds

4,045

(248

3,797

3,797

Subtotal

6,281

(248

6,033

2,236

3,797

Level 2 (b):

U.S. Treasury securities

39,177

11

(62

39,126

629

8,498

29,999

U.S. agency securities

16,087

(37

16,057

1,016

3,854

11,187

Non-U.S. government securities

5,470

25

(141

5,354

276

5,078

Certificates of deposit and time deposits

1,438

1,438

668

494

276

Commercial paper

2,212

2,212

1,122

991

99

Corporate securities

57,709

297

(221

57,785

7,658

50,125

Municipal securities

6,246

49

(13

6,282

1,021

5,261

Mortgage- and asset-backed securities

16,221

23

(93

16,151

45

16,106

Subtotal

144,560

412

(567

144,405

3,437

22,837

118,131

Total

159,245

412

(815

158,842

14,077

26,634

118,131

Table of Contents

September 28, 2013

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

8,705

8,705

8,705

Level 1 (a):

Money market funds

1,793

1,793

1,793

Mutual funds

3,999

(197

3,802

3,802

Subtotal

5,792

(197

5,595

1,793

3,802

Level 2 (b):

U.S. Treasury securities

27,642

24

(47

27,619

431

7,554

19,634

U.S. agency securities

16,878

12

(52

16,838

177

3,412

13,249

Non-U.S. government securities

5,545

35

(137

5,443

50

313

5,080

Certificates of deposit and time deposits

2,344

2,344

1,264

844

236

Commercial paper

2,998

2,998

1,835

1,163

Corporate securities

54,586

275

(252

54,609

8,077

46,532

Municipal securities

6,257

45

(22

6,280

1,114

5,162

Mortgage- and asset-backed securities

16,396

23

(89

16,330

16,322

Subtotal

132,646

414

(599

132,461

3,761

22,485

106,215

Total

147,143

414

(796

146,761

14,259

26,287

106,215

(a)

The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.

(b)

The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and

liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

The Company may sell certain of its marketable securities prior to their stated maturities for strategic

reasons including, but not limited to, anticipation of credit deterioration and duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three months ended

December 28, 2013 and December 29, 2012. The maturities of the Company s long-term marketable securities generally range from one to five years.

As of December 28, 2013 and September 28, 2013, gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.

As of December 28, 2013, the Company considers the declines in market value of its marketable securities investment

portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to

any one issuer. The policy requires investments generally to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio.

When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto,

changes in market interest rates, and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. During the three months ended

December 28, 2013 and December 29, 2012, the Company did not recognize any significant impairment charges.

Table of Contents

Derivative Financial Instruments

The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk. The Company may enter

into forward contracts, option contracts, swaps, or other derivative instruments to offset some of the risk on expected future cash flows, on net investments in certain foreign subsidiaries, and on certain existing assets and liabilities.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s

subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion

of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to

12 months.

To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates,

the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.

To help protect against adverse fluctuations in interest rates, the Company may enter into interest rate swaps, options, or other

instruments to offset a portion of the changes in income or expense due to fluctuations in interest rates.

The Company may

also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the

Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no

assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.

The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment for these instruments is based on whether the instruments are

designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income

( OCI ) as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are

adjusted to fair value through earnings in the financial statement line item to which the derivative relates.

Deferred gains

and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory

purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized as a component of other

income/(expense), net in the same period as the related income or expense is recognized. The Company s hedged foreign currency transactions and hedged interest rate transactions as of December 28, 2013 are expected to occur within 12

months and five years, respectively.

10

Table of Contents

Derivative instruments designated as cash flow hedges must be de-designated as hedges when

it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified

immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any

significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 28, 2013 and December 29, 2012.

The Company s unrealized net gains and losses on net investment hedges, included in the cumulative translation adjustment account of

AOCI, were not significant as of December 28, 2013 and September 28, 2013. The ineffective portions and amounts excluded from the effectiveness test of net investment hedges are recorded in other income and expense.

The gain/loss recognized in other income and expense for foreign currency forward and option contracts not designated as hedging

instruments was not significant during the three months ended December 28, 2013 and December 29, 2012.

The

following table shows the notional principal amounts of the Company s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of December 28, 2013 and September 28,

2013 (in millions):

December 28, 2013

September 28, 2013

Notional

Principal

Credit Risk

Amounts

Notional

Principal

Credit Risk

Amounts

Instruments designated as accounting hedges:

Foreign exchange contracts

23,553

331

35,013

159

Interest rate contracts

3,000

55

3,000

44

Instruments not designated as accounting hedges:

Foreign exchange contracts

16,859

48

16,131

25

The notional principal amounts for outstanding derivative instruments provide one measure of the

transaction volume outstanding and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that

are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company s gross

exposure on these transactions may be further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as currency and interest rates change. Although the table

above reflects the notional principal and credit risk amounts of the Company s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The

amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.

11

Table of Contents

The Company generally enters into master netting arrangements, which are designed to reduce

credit risk by permitting net settlement of transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net

fair value of certain financial instruments fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of December 28, 2013, the Company received

$165 million of cash collateral related to the derivative instruments under its collateral security arrangements, which were recorded as accrued expenses in the Condensed Consolidated Balance Sheet. As of September 28, 2013, the Company posted

cash collateral related to the derivative instruments under its collateral security arrangements of $164 million, which it recorded as other current assets in the Condensed Consolidated Balance Sheet. The Company did not have any derivative

instruments with credit-risk related contingent features that would require it to post additional collateral as of December 28, 2013 or September 28, 2013.

Under master netting arrangements with the respective counterparties to the Company s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by

one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis in its Condensed Consolidated Balance Sheets. As of December 28, 2013 and September 28, 2013,

the potential effects of these rights of set-off associated with the Company s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $356 million and

$333 million, respectively, resulting in net derivative liabilities of $66 million and $57 million, respectively.

The following tables show the Company s derivative instruments at gross fair value as reflected in the Condensed Consolidated

Balance Sheets as of December 28, 2013 and September 28, 2013 (in millions):

December 28, 2013

Fair Value of

Derivatives

Designated

as Hedge

Instruments

Fair Value of

Derivatives

Not Designated

as Hedge

Instruments

Total

Fair

Value

Derivative assets (a):

Foreign exchange contracts

263

48

311

Interest rate contracts

55

55

Derivative liabilities (b):